Research & Clinical Trials
- Islet transplantation in type 1 diabetes using immunosuppression and strategies to improve long term graft survival
-
- Investigator: Ali Naji, MD, PhD
- Sponsored by: National Institutes of Health
- Using anti-B lymphocyte agent rituximab (Rituxan) to improve long-term graft survival
-
- Investigator: Ali Naji, MD, PhD
- Sponsored by: National Institutes of Health
- Islet transplantation vs. intensive insulin therapy in patients with type 1 diabetes who have already received a kidney transplant
-
- Investigator: Ali Naji, MD, PhD
- Sponsored by: National Institutes of Health
For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.